Prime-boost Vaccination based on DNA and Protein-loaded Microspheres for Tuberculosis Prevention
- 1 May 2004
- journal article
- research article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 12 (4) , 195-203
- https://doi.org/10.1080/10611860410001723126
Abstract
We evaluated the use of a vaccine formulation based on a mixture of two different PLGA microspheres, composed by faster and slower release profiles, containing DNA encoding hsp65 and the recombinant hsp65 protein, respectively, aiming to DNA priming and protein boost after a single dose vaccination. The combination of PLGA50:50 microspheres containing DNA-hsp65 and trehalose dimycolate (TDM) with PLGA75:25 microspheres containing recombinant hsp65 (prime-boost Me) was able to induce high levels of anti-hsp65 specific antibodies. The serum levels of these specific antibodies remained high during 90 days after vaccination, whereas the DNA Me formulation based only in DNA-hsp65 plus TDM-loaded microspheres was not able to sustain the high antibody levels during the same period. Production of IFN-γ was significant in animals vaccinated with both formulations, while the prime-boost Me vaccinated mice sustained higher levels of this cytokine during all the evaluation period. Thus, prime-boost strategy by using biodegradable microspheres seems to be a promising strategy to stimulate long-lasting immune response.Keywords
This publication has 32 references indexed in Scilit:
- A DNA Prime- Mycobacterium bovis BCG Boost Vaccination Strategy for Cattle Induces Protection against Bovine TuberculosisInfection and Immunity, 2003
- The combination of plasmid interleukin-12 with a single DNA vaccine is more effective than Mycobacterium bovis (bacille Calmette-Guerin) in protecting against systemic Mycobacterim avium infectionImmunology, 2003
- Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosisGene Therapy, 2003
- DNA Immunization with Hepatitis C Virus (HCV) Polycistronic Genes or Immunization by HCV DNA Priming-Recombinant Canarypox Virus Boosting Induces Immune Responses and Protection from Recombinant HCV-Vaccinia Virus Infection in HLA-A2.1-Transgenic MiceJournal of Virology, 2003
- Evaluation in rabbits of different anti-SHIV vaccine strategies based on DNA/fowlpox priming and virus-like particle boostingFEMS Immunology & Medical Microbiology, 2003
- The Mycobacterium leprae hsp65 Displays Proteolytic Activity. Mutagenesis Studies Indicate That the M. leprae hsp65 Proteolytic Activity Is Catalytically Related to the HslVU ProteaseBiochemistry, 2002
- Induction of Cell-Mediated Immunity againstMycobacterium tuberculosisUsing DNA Vaccines Encoding Cytotoxic and Helper T-Cell Epitopes of the 38-Kilodalton ProteinInfection and Immunity, 2001
- Cytotoxic T cells and mycobacteriaFEMS Microbiology Letters, 2001
- Tissue Distribution and Persistence in Mice of Plasmid DNA Encapsulated in a PLGA-Based Microsphere Delivery VehicleJournal of Drug Targeting, 2000
- Characterization of the memory/activated T cells that mediate the long‐lived host response against tuberculosis after bacillus Calmette–Guérin or DNA vaccinationImmunology, 1999